{
    "root": "3596a066-4a99-1e8b-e063-6294a90a7346",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "AMOXICILLIN",
    "value": "20250515",
    "ingredients": [
        {
            "name": "D&C RED NO. 28",
            "code": "767IP0Y5NH"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "FD&C RED NO. 40",
            "code": "WZB9127XOA"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "AMOXICILLIN",
            "code": "804826J2HU",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_2676"
        }
    ],
    "indications": {
        "text": "amoxicillin penicillin-class antibacterial indicated treatment infections due susceptible strains designated microorganisms . infections ear , nose , throat , genitourinary tract , skin skin structure , lower respiratory tract . ( 1.1 1.4 ) combination treatment h. pylori infection duodenal ulcer disease . ( 1.5 ) reduce development drug-resistant bacteria maintain effectiveness amoxicillin antibacterial drugs , amoxicillin used treat prevent infections proven strongly suspected caused bacteria . ( 1.6 )",
        "doid_entities": [
            {
                "text": "duodenal ulcer (DOID:1724)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1724"
            },
            {
                "text": "disease (DOID:4)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "adults , 750-1750 mg/day divided doses every 8 12 hours . pediatric patients > 3 months age , 20 45 mg/kg/day divided doses every 8 12 hours . refer full prescribing information dosing regimens . ( 2.1 , 2.2 , 2.3 ) upper dose neonates infants \u2264 3 months 30 mg/kg/day divided every 12 hours . ( 2.2 ) dosing h. pylor infection : triple therapy : 1 gram amoxicillin , 500 mg clarithromycin , 30 mg lansoprazole , given twice daily ( every 12 hours ) 14 days . dual therapy : 1 gram amoxicillin 30 mg lansoprazole , given three times daily ( every 8 hours ) 14 days . ( 2.3 ) reduce dose patients severe renal impairment ( gfr < 30 ml/min ) . ( 2.4 )",
        "doid_entities": [],
        "orphanet_entities": [
            {
                "disease": "severe renal impairment",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_447788"
            }
        ]
    },
    "warningsAndPrecautions": "amoxicillin capsules , usp : capsule amoxicillin , royal blue opaque cap pink opaque body , contains 250 mg 500 mg amoxicillin trihydrate . cap body 250 mg capsule imprinted `` amoxil \u00ae `` `` 250 `` ; cap body 500 mg capsule imprinted `` amoxil \u00ae `` `` 500 `` . 250 mg capsule ndc 81964-225-01 bottles 100 ndc 81964-225-05 bottles 500 500 mg capsule ndc 81964-205-01 bottles 100 ndc 81964-205-05 bottles 500 ndc 81964-205-10 bottles 100 ( child resistant cap ) ndc 81964-205-60 bottles 60 ( child resistant cap ) amoxicillin capsules 500 mg , usp : capsule amoxicillin , white cap body , contains 500 mg amoxicillin trihydrate . cap body 500 mg capsule imprinted \u201c amoxil \u00ae \u201d \u201c 500 \u201d . 500 mg capsule ndc 81964-350-10 bottles 100 ( child resistant cap ) ndc 81964-350-60 bottles 60 ( child resistant cap ) ndc 81964-350-98 container 8.00 kg amoxicillin oral suspension , usp : 5 ml reconstituted strawberry flavored suspension contains 125 mg amoxicillin trihydrate . 5 ml reconstituted bubble-gum flavored suspension contains 250 mg amoxicillin trihydrate . 125 mg/5 ml ndc 81964-222-80 80 ml bottle ndc 81964-222-52 100 ml bottle ndc 81964-222-53 150 ml bottle 250 mg/5 ml ndc 81964-209-80 80 ml bottle ndc 81964-209-52 100 ml bottle ndc 81964-209-53 150 ml bottle store 20\u00b0c 25\u00b0c ( 68\u00b0f 77\u00b0f ) [ usp controlled room temperature ] . dispense tight container defined usp . keep drugs reach children .",
    "adverseReactions": "amoxicillin contraindicated patients experienced serious hypersensitivity reaction ( e.g . , anaphylaxis stevens-johnson syndrome ) amoxicillin \u200b\u03b2\u2011lactam antibiotics ( e.g . , penicillins cephalosporins ) .",
    "indications_original": "Amoxicillin is a penicillin-class antibacterial indicated for treatment of infections due to susceptible strains of designated microorganisms. Infections of the ear, nose, throat, genitourinary tract, skin and skin structure, and lower respiratory tract. ( 1.1 to 1.4 ) In combination for treatment of H. pylori infection and duodenal ulcer disease. ( 1.5 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin and other antibacterial drugs, amoxicillin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. ( 1.6 )",
    "contraindications_original": "In adults, 750-1750 mg/day in divided doses every 8 to 12 hours. In Pediatric Patients\u00a0> 3 Months of Age, 20 to 45 mg/kg/day in divided doses every 8 to 12 hours. Refer to full\u00a0prescribing information for specific dosing regimens. ( 2.1 , 2.2 , 2.3 ) The upper dose for neonates and infants \u2264 3 months is 30 mg/kg/day divided every\u00a012 hours. ( 2.2 ) Dosing for H. pylor i Infection: Triple therapy: 1 gram amoxicillin, 500 mg clarithromycin,\u00a0and 30 mg lansoprazole, all given twice daily (every 12 hours) for 14 days. Dual\u00a0therapy: 1 gram amoxicillin and 30 mg lansoprazole, each given three times daily\u00a0(every 8 hours) for 14 days. ( 2.3 ) Reduce the dose in patients with severe renal impairment (GFR <30 mL/min). ( 2.4 )",
    "warningsAndPrecautions_original": "Amoxicillin Capsules, USP: Each capsule of amoxicillin, with royal blue opaque cap and pink opaque body, contains 250 mg or 500 mg amoxicillin as the trihydrate. The cap and body of the 250 mg capsule are imprinted with \"AMOXIL \n  \u00ae\" over \"250\"; the cap and body of the 500 mg capsule are imprinted with \"AMOXIL \n  \u00ae\" over \"500\".\n  \n                     250 mg Capsule\n                     \nNDC 81964-225-01 Bottles of 100\n \n                  NDC 81964-225-05 Bottles of 500\n                  \n                     500 mg Capsule\n                     \nNDC 81964-205-01 Bottles of 100\n \n                  NDC 81964-205-05 Bottles of 500\n                  NDC 81964-205-10 Bottles of 100 (with child resistant cap)\n                  NDC 81964-205-60 Bottles of 60 (with child resistant cap)\n                  \n                  \n                     Amoxicillin Capsules 500 mg, USP: Each capsule of amoxicillin, with white cap and body, contains 500 mg of amoxicillin as the trihydrate. The cap and body of the 500 mg capsule are imprinted with \u201cAMOXIL\n  \u00ae\u201d over \u201c500\u201d.\n \n                  \n                  \n                     500 mg Capsule\n                  \n                  NDC 81964-350-10 Bottles of 100 (with child resistant cap)\n  \nNDC 81964-350-60 Bottles of 60 (with child resistant cap)\n  \nNDC 81964-350-98 Container of 8.00 kg\n \n                  \n                  \n                     Amoxicillin for Oral Suspension, USP: Each 5 mL of reconstituted strawberry flavored suspension contains 125 mg amoxicillin as the trihydrate. Each 5 mL of reconstituted bubble-gum flavored suspension contains 250 mg amoxicillin as the trihydrate.\n  \n                     125 mg/5 mL\n                     \nNDC 81964-222-80 80 mL bottle\n \n                  NDC 81964-222-52 100 mL bottle\n                  NDC 81964-222-53 150 mL bottle\n                  \n                     250 mg/5 mL\n                     \nNDC 81964-209-80 80 mL bottle\n \n                  NDC 81964-209-52 100 mL bottle\n                  NDC 81964-209-53 150 mL bottle\n                  \n                     \n                     Store at \n                     20\u00b0C to 25\u00b0C (68\u00b0F to 77\u00b0F) [\n                     See USP Controlled Room Temperature].\n                     \nDispense in a tight container as defined in the USP.\n \n                  \n                     \nKeep this and all drugs out of the reach of children.",
    "adverseReactions_original": "Amoxicillin is contraindicated in patients who have experienced a serious hypersensitivity reaction (e.g., anaphylaxis or Stevens-Johnson syndrome) to amoxicillin or to other\n \n  \u200b\u03b2\u2011lactam antibiotics (e.g., penicillins and cephalosporins).",
    "drug": [
        {
            "name": "AMOXICILLIN",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_2676"
        }
    ]
}